Ova donors demand compensation from government
By Asia News,
AsiaNews.it
| 02. 07. 2006
Seoul (AsiaNews) _ A coalition of 35 women_s groups filed a suit for compensation against the South Korean government on behalf of women suffering from side-effects after making uninformed ova donations to Prof Hwang Woo-suk for his research on stem cell embryos.
The women_s groups in association with Lawyers for a Democratic Society (Minbyun) claim that the donors who provided the _research material_ to the now disgraced researcher received no information on the side effects of excessive ova collection.
During the investigation into the fraudulent study, it was found that Hwang_s team used 2,221 ova, about fivefold the number Hwang had previously claimed, and that about 20 per cent of the donors have suffered side-effects from this invasive practice.
_Fifteen women donated eggs more than twice. The Mizmedi Hospital team even collected ova twice from a woman, who was hospitalized for side-effects after each donation,__ the women_s groups said in a statement. _It is an example of how the embryonic stem cell research, which received full national support, trampled on women_s human rights,_ the press release also said.
The groups...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...